Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
7.69
-0.06 (-0.77%)
Sep 29, 2026, 4:00 PM EDT - Market closed
Achieve Life Sciences Employees
Achieve Life Sciences had 28 employees as of December 31, 2025. The number of employees increased by 3 or 12.00% compared to the previous year.
Employees
28
Change (1Y)
3
Growth (1Y)
12.00%
Revenue / Employee
n/a
Profits / Employee
-$4,072,857
Market Cap
791.32M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 28 | 3 | 12.00% |
| Dec 31, 2024 | 25 | 3 | 13.64% |
| Dec 31, 2023 | 22 | 2 | 10.00% |
| Dec 31, 2022 | 20 | 4 | 25.00% |
| Dec 31, 2021 | 16 | 3 | 23.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Gyre Therapeutics | 625 |
| Ginkgo Bioworks Holdings | 485 |
| Geron | 258 |
| 4D Molecular Therapeutics | 196 |
| Solid Biosciences | 121 |
| Annexon | 92 |
| Inventiva | 77 |
| Aclaris Therapeutics | 73 |
ACHV News
- 12 hours ago - Achieve Life Sciences initiated with a Buy at Stifel - TheFly
- 1 day ago - Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026 - GlobeNewsWire
- 26 days ago - Achieve Life Sciences Announced Granting of New Hire Inducement Awards - GlobeNewsWire
- 6 weeks ago - Achieve Life Sciences price target lowered to $18 from $20 at Raymond James - TheFly
- 6 weeks ago - Achieve Life Sciences initiated with an Overweight at Morgan Stanley - TheFly
- 7 weeks ago - Achieve Life Sciences Earnings release: Q2 2026 - Filings
- 7 weeks ago - Achieve Life Sciences Quarterly report: Q2 2026 - Filings
- 7 weeks ago - Achieve Life Sciences reports Q2 EPS (80c), consensus (16c) - TheFly